Omalizumab added to allergen immunotherapy increased the effect of therapy in patients with severe local allergic rhinitis
Background Allergen immunotherapy (AIT) is effective in patient with local allergic rhinitis (LAR). However, AIT may not always achieve the optimal treatment effect. Objective To present short study with clinical cases of LAR combined therapy with sublingual immunotherapy (SLIT) and omalizumab in pa...
Saved in:
Main Authors: | Andrzej Bozek (Author), Renata Kozłowska (Author), Maciej Misiołek (Author), Wojciech Ścierski (Author), Radosław Gawlik (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2022-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Effectiveness of Sublingual Allergen-Specific Immunotherapy in Children with Allergic Rhinitis
by: M.P. Prokhorova
Published: (2015) -
Use of omalizumab and allergen-specific immunotherapy for the treatment of respiratory allergic diseases in children and adults
by: A. S. Prilutskiy, et al.
Published: (2024) -
Predictors for Short-Term Efficacy of Allergen-Specific Sublingual Immunotherapy in Children with Allergic Rhinitis
by: Wenlong Liu, et al.
Published: (2020) -
Responders and nonresponders to pharmacotherapy and allergen immunotherapy
by: Marek Jakalski, et al.
Published: (2019) -
Skin prick tests and subcutaneous immunotherapy with standardized allergens in children with moderate-to-severe allergic rhinitis
by: Nihar Ranjan Mishra, et al.
Published: (2021)